Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001595585-22-000004
Filing Date
2022-01-04
Accepted
2022-01-04 16:20:22
Documents
1
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_164133119408830.html 4  
1 FORM 4 wf-form4_164133119408830.xml 4 3653
  Complete submission text file 0001595585-22-000004.txt   5114
Mailing Address 7000 SHORELINE COURT, SUITE 201 SOUTH SAN FRANCISCO CA 94080
Business Address 7000 SHORELINE COURT, SUITE 201 SOUTH SAN FRANCISCO CA 94080 415-429-7800
Tricida, Inc. (Issuer) CIK: 0001595585 (see all company filings)

EIN.: 463372526 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 7000 SHORELINE COURT, SUITE 201 SOUTH SAN FRANCISCO CA 94080
Business Address
Otto Dawn Parsell (Reporting) CIK: 0001748808 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38558 | Film No.: 22506251